BIOMAT Database Logo BIOMAT Database Logo

Dlk1 in normal and abnormal hematopoiesis. 2005

S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA, Los Angeles, CA 90048, USA.

Dlk1 (Pref-1) is a transmembrane and secreted protein, which is a member of the epidermal growth factor-like family, homologous to Notch/Delta/Serrate. We have found by real-time RT-PCR that Dlk1 mRNA levels were high in CD34(+) cells in 10 of 12 MDS samples compared with CD34(+) cells from 11 normals. Also, Dlk1 mRNA was elevated in mononuclear, low density bone marrow cells from 11/38 MDS patients, 5/11 AML M6 and 2/4 AML M7 samples. Furthermore, 5/6 erythroleukemia and 2/2 megakaryocytic leukemia cell lines highly expressed Dlk1 mRNA. Levels of Dlk1 mRNA markedly increased during megakaryocytic differentiation of both CMK megakaryoblasts as well as normal CD34(+) hematopoietic stem cells. High serum levels of Dlk1 occurred in RA (4/10) and essential thrombocythemia (2/10) patients. Functional studies showed that forced expression of Dlk1 enhanced proliferation of K562 cells growing in 1% fetal bovine serum. Analysis of hematopoiesis of Dlk1 knockout mice suggested that Dlk1 contributed to granulocyte, megakaryocyte and B-cell clonogenic growth and was needed for generation of splenic B-cells. In summary, Dlk1 is overexpressed in selected samples of MDS (especially RA and RAEB) and AML (particularly M6, M7), and it appears to be associated with normal development of megakaryocytes and B cells.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Runx1/AML1 in normal and abnormal hematopoiesis.
July 2005, International journal of hematology,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Guest editorial: Regulatory signaling in normal and abnormal hematopoiesis.
June 2018, International journal of hematology,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Role of Rho kinases in abnormal and normal hematopoiesis.
July 2014, Current opinion in hematology,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Role of bone marrow matrix in normal and abnormal hematopoiesis.
June 1994, Critical reviews in oncology/hematology,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Ex vivo mimicry of normal and abnormal human hematopoiesis.
April 2012, Journal of visualized experiments : JoVE,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
The role of telomere binding molecules for normal and abnormal hematopoiesis.
June 2018, International journal of hematology,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
[Abnormal hematopoiesis in Down syndrome].
October 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
[Normal hematopoiesis].
February 1990, Gematologiia i transfuziologiia,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Abnormal hematopoiesis in Gab2 mutant mice.
July 2007, Blood,
S Sakajiri, and J O'kelly, and D Yin, and C W Miller, and W K Hofmann, and K Oshimi, and L-Y Shih, and K-H Kim, and H S Sul, and C H Jensen, and B Teisner, and N Kawamata, and H P Koeffler
Parentally imprinted genes regulate hematopoiesis-new evidence from the Dlk1-Gtl2 locus.
January 2016, Stem cell investigation,
Copied contents to your clipboard!